TY - JOUR
T1 - Network Localization of Alien Limb in Patients with Corticobasal Syndrome
AU - for the 4 Repeat Tau Neuroimaging Initiative
AU - Tetreault, Aaron M.
AU - Phan, Tony
AU - Petersen, Kalen J.
AU - Claassen, Daniel O.
AU - Neth, Byran J.
AU - Graff-Radford, Jonathan
AU - Albrecht, Franziska
AU - Fliessbach, Klaus
AU - Schneider, Anja
AU - Synofzik, Matthis
AU - Diehl-Schmid, Janine
AU - Otto, Markus
AU - Schroeter, Matthias L.
AU - Darby, Richard Ryan
N1 - Funding Information:
This work was supported by grants from the Alzheimer's Association (R.R.D.), the BrightFocus Foundation (R.R.D.), and Vanderbilt Institute for clinical and translational research (R.R.D.). The FTLD Consortium Study Germany has been supported by the German Federal Ministry of Education and Research (BMBF; grant number FKZ O1GI1007A). M.L.S. has been supported by the German Research Foundation (DFG; SCHR 774/5-1). Data collection and sharing for this project was funded by the 4-Repeat Tauopathy Neuroimaging Initiative (4RTNI; National Institutes of Health Grant R01 AG038791) and through generous contributions from the Tau Research Consortium. The study is coordinated through the University of California, San Francisco, Memory and Aging Center. The 4RTNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Funding Information:
This work was supported by grants from the Alzheimer's Association (R.R.D.), the BrightFocus Foundation (R.R.D.), and Vanderbilt Institute for clinical and translational research (R.R.D.). The FTLD Consortium Study Germany has been supported by the German Federal Ministry of Education and Research (BMBF; grant number FKZ O1GI1007A). M.L.S. has been supported by the German Research Foundation (DFG; SCHR 774/5‐1). Data collection and sharing for this project was funded by the 4‐Repeat Tauopathy Neuroimaging Initiative (4RTNI; National Institutes of Health Grant R01 AG038791) and through generous contributions from the Tau Research Consortium. The study is coordinated through the University of California, San Francisco, Memory and Aging Center. The 4RTNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Funding Information:
Data for our main analyses were obtained from the 4‐Repeat Tau Neuroimaging Initiative (4RTNI; http://4rtni-ftldni.ini.usc.edu ). The 4RTNI was launched in early 2011 and is funded through the National Institute of Aging and the Tau Research Consortium. The primary goal of 4RTNI is to identify neuroimaging and biomarker indicators for disease progression in the 4‐repeat tauopathy neurodegenerative diseases, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). The Principal Investigator of 4RTNI is Dr. Adam Boxer, MD, PhD, at the University of California, San Francisco. The data is the result of collaborative efforts at 4 sites in North America. For more information on 4RTNI, please visit: http://memory.ucsf.edu/research/studies/4rtni .
Publisher Copyright:
© 2020 American Neurological Association
PY - 2020/12
Y1 - 2020/12
N2 - Objective: Perirolandic atrophy occurs in corticobasal syndrome (CBS) but is not specific versus progressive supranuclear palsy (PSP). There is heterogeneity in the locations of atrophy outside the perirolandic cortex and it remains unknown why atrophy in different locations would cause the same CBS-specific symptoms. In prior work, we used a wiring diagram of the brain called the human connectome to localize lesion-induced disorders to symptom-specific brain networks. Here, we use a similar technique termed “atrophy network mapping” to localize single-subject atrophy maps to symptom-specific brain networks. Methods: Single-subject atrophy maps were generated by comparing cortical thickness in patients with CBS versus controls. Next, we performed seed-based functional connectivity using a large normative connectome to determine brain regions functionally connected to each patient's atrophied locations. Results: Patients with CBS had perirolandic atrophy versus controls at the group level, but locations of atrophy in CBS were heterogeneous outside of the perirolandic cortex at the single-subject level (mean spatial correlation = 0.04). In contrast, atrophy occurred in locations functionally connected to the perirolandic cortex in all patients with CBS (spatial correlation = 0.66). Compared with PSP, patients with CBS had atrophy connected to a network of higher-order sensorimotor regions beyond perirolandic cortex, matching a CBS atrophy network from a recent meta-analysis. Finally, atrophy network mapping identified a symptom-specific network for alien limb, matching a lesion-induced alien limb network and a network associated with agency in healthy subjects. Interpretation: We identified a syndrome-specific network for CBS and symptom-specific network for alien limb using single-subject atrophy maps and the human connectome. ANN NEUROL 2020;88:1118–1131.
AB - Objective: Perirolandic atrophy occurs in corticobasal syndrome (CBS) but is not specific versus progressive supranuclear palsy (PSP). There is heterogeneity in the locations of atrophy outside the perirolandic cortex and it remains unknown why atrophy in different locations would cause the same CBS-specific symptoms. In prior work, we used a wiring diagram of the brain called the human connectome to localize lesion-induced disorders to symptom-specific brain networks. Here, we use a similar technique termed “atrophy network mapping” to localize single-subject atrophy maps to symptom-specific brain networks. Methods: Single-subject atrophy maps were generated by comparing cortical thickness in patients with CBS versus controls. Next, we performed seed-based functional connectivity using a large normative connectome to determine brain regions functionally connected to each patient's atrophied locations. Results: Patients with CBS had perirolandic atrophy versus controls at the group level, but locations of atrophy in CBS were heterogeneous outside of the perirolandic cortex at the single-subject level (mean spatial correlation = 0.04). In contrast, atrophy occurred in locations functionally connected to the perirolandic cortex in all patients with CBS (spatial correlation = 0.66). Compared with PSP, patients with CBS had atrophy connected to a network of higher-order sensorimotor regions beyond perirolandic cortex, matching a CBS atrophy network from a recent meta-analysis. Finally, atrophy network mapping identified a symptom-specific network for alien limb, matching a lesion-induced alien limb network and a network associated with agency in healthy subjects. Interpretation: We identified a syndrome-specific network for CBS and symptom-specific network for alien limb using single-subject atrophy maps and the human connectome. ANN NEUROL 2020;88:1118–1131.
UR - http://www.scopus.com/inward/record.url?scp=85091751925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091751925&partnerID=8YFLogxK
U2 - 10.1002/ana.25901
DO - 10.1002/ana.25901
M3 - Article
C2 - 32935385
AN - SCOPUS:85091751925
SN - 0364-5134
VL - 88
SP - 1118
EP - 1131
JO - Annals of neurology
JF - Annals of neurology
IS - 6
ER -